Antenatal care during the COVID-19 pandemic

Authors

  • Devdatt Laxman Pitale Department of Obstetrics and Gynecology, INHS ASVINI Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20204286

Keywords:

Antenatal, Delivery, Pandemic, Protocol

Abstract

Background: COVID-19 pandemic has affected the daily living globally. It has added to the stress of day to day life. COVID-19 is associated with severe disease in high-risk population groups with increased mortality risk. COVID-19 and it’s impact on pregnancy needs extensive research. Early research data does not suggest any increased risk in the pregnant population and Vertical transmission is yet to be confirmed. As of now no standard protocol is available for management of COVID-19 .Social distancing is the best possible mechanism available to protect patients and health care personnel from COVID-19. The aim of this study is to know the effectiveness of protocol based Antenatal care during COVID-19 pandemic.

Methods: This study was conducted at the Antenatal clinic. A total of 40 antenatal cases who satisfied inclusion and exclusion criteria were selected for the above study. They were assessed at the antenatal clinic following a modified protocol.

Results: Majority of the pregnant women in the study group were primigravidas and belonged to the age group of 21-25 years. They were called for Antenatal check-ups as per the protocol specifically modified taking into consideration the COVID-19 pandemic. 80% of the deliveries in present study were normal delivery and only in obstetric emergencies LSCS was performed.

Conclusions: Antenatal care in COVID-19 pandemic is challenging yet essential. Following a protocol based approach is the key to management of Antenatal care amidst the pandemic. It is cost-effective and has an easy learning curve.

 

References

Linton NM, Kobayashi T, Yang Y. Incubation period and other epidemiological characteristics of 2019 novel coronavirus infections with right truncation: a statistical analysis of publicly available case data. J Clin Med. 2020;9(02):E538.

CDC COVID-19 Response Team. Severe outcomes among patients with coronavirus disease 2019 (COVID-19) - United States, February 12-March 16, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(12):343-6.

Control ECf DPa. Daily risk assessment on COVID-19, 13 March 2020. In: Control ECfDPa ed; 2020. Available at: https://www. ecdc.europa.eu/en/current-risk-assessment-novel-coronavirussituation. Accessed 13th April 2020.

Lei Pan MM, Hong GR, Yang P. Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study. Am J Gastroenterol 2020. Available at: https://journals.lww.com/ajg/Documents/COVID_Digestive_Symptoms_AJG_Preproof.pdf. Accessed on 13th April 2020

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E. Latin American Network of Coronavirus Disease 2019COVID-19 Research (LANCOVID-19). Clinical, laboratory and imaging features of COVID-19: a systematic review and metaanalysis. Travel Med Infect Dis. 2020;34:101623.

Bhatraju PK, Ghassemieh BJ, Nichols M. Covid-19 in critically ill patients in the Seattle region - case series. N Engl J Med. 2020;382:2012-22.

Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020.

Wang D, Hu B, Hu C. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.

Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020:S1473-3099(20)30195-X.

Novel coronavirus pneumonia emergency response epidemiology team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China] (in Chinese). Zhonghua Liu Xing Bing Xue Za Zhi. 2020;41(02):145-51.

Gautret P, Lagier JC, Parola P. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial. Int J Antimicrob Agents. 2020:105949.

Cortegiani A, Ingoglia G, Ippolito M, Giarratano A, Einav S. A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19. J Crit Care. 2020:S0883-9441(20):30390-7.

CDC. What Healthcare Personnel Should Know about Caring for Patients with Confirmed or Possible COVID-19 Infection. Available at: https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-patients-H.pdf.

Hughes DK. Consideration for the Obstetric care during COVID19 pandemic. Am J Perinatol. 2020;37(08):773-9.

American College of Obstetricians and Gynecologists; Public Health Preparedness Expert Work Group. COVID-19 FAQs for Obstetrician-Gynecologists, Obstetrics. Available at: https:// www.acog.org/clinical-information/physician-faqs/covid-19faqs-for-ob-gyns-obstetrics. Accessed 8th April 2020.

The Society for Maternal-Fetal Medicine (SMFM). Sarah DottersKatz M, MMHPE; and Brenna L. Hughes, MD, MSc. Coronavirus (COVID-19) and Pregnancy: What Maternal-Fetal Medicine Subspecialists Need to Know. Available at: https://s3.amazonaws.com/cdn.smfm.org/media/2262/COVID19_PDF.pdf. Accessed 13th April 2020.

CDC. Interim Guidance on Breastfeeding for a Mother Confirmed or Under Investigation For COVID-19. Available at: http://www.e-lactancia.org/media/papers/Interim_Guidance_on_Breastfeeding_for_ a_Mother_COVID-19-CDC-2020.pdf. Accessed 13th April 2020.

Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle east respiratory syndrome coronavirus (MERS-CoV) infection during pregnancy: report of two cases and review of the literature. J Microbiol Immunol Infect 2019;52(03):501-3.

Wong SF, Chow KM, Leung TN. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(01):292-7.

Rasmussen IS, Mortensen LH, Krause TG, Nybo Andersen AM. The association between seasonal influenza-like illness cases and foetal death: a time series analysis. Epidemiol Infect. 2018;147:1-7.

Zhu H, Wang L, Fang C. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9 (01):51-60.

Wang X, Zhou Z, Zhang J, Zhu F, Tang Y, Shen X. A case of 2019 Novel Coronavirus in a pregnant woman with preterm delivery. Clin Infect Dis. 2020:ciaa200.

Chen H, Guo J, Wang C. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. Lancet. 2020;395(10226):809-15.

Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J Infect. 2020.

Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Available at: https://www.who.int/docs/ default-source/coronaviruse/who-china-joint-mission-on-covid19-final-report.pdf. Accessed April 8, 2020

Chen S, Liao E, Shao Y. Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia. J Med Virol. 2020.

Dong L, Tian J, He S. Possible Vertical Transmission of SARS-CoV-2 From an Infected Mother to Her Newborn. JAMA. 2020.

Downloads

Published

2020-09-25

Issue

Section

Original Research Articles